PL3041837T3 - Kryształ o specyficznym pokroju kryształu i kompozycja farmaceutyczna zawierająca ten kryształ jako składnik czynny - Google Patents
Kryształ o specyficznym pokroju kryształu i kompozycja farmaceutyczna zawierająca ten kryształ jako składnik czynnyInfo
- Publication number
- PL3041837T3 PL3041837T3 PL14722366T PL14722366T PL3041837T3 PL 3041837 T3 PL3041837 T3 PL 3041837T3 PL 14722366 T PL14722366 T PL 14722366T PL 14722366 T PL14722366 T PL 14722366T PL 3041837 T3 PL3041837 T3 PL 3041837T3
- Authority
- PL
- Poland
- Prior art keywords
- crystal
- pharmaceutical composition
- active ingredient
- composition containing
- habit
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title 3
- 239000004480 active ingredient Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013185313A JP5680161B1 (ja) | 2013-09-06 | 2013-09-06 | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
| EP14722366.3A EP3041837B1 (en) | 2013-09-06 | 2014-04-11 | Crystal having specific crystal habit and pharmaceutical composition containing the crystal as active ingredient |
| PCT/JP2014/060993 WO2015033612A1 (en) | 2013-09-06 | 2014-04-11 | Crystal having specific crystal habit and pharmaceutical composition containing the crystal as active ingredient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3041837T3 true PL3041837T3 (pl) | 2022-06-06 |
Family
ID=50680085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14722366T PL3041837T3 (pl) | 2013-09-06 | 2014-04-11 | Kryształ o specyficznym pokroju kryształu i kompozycja farmaceutyczna zawierająca ten kryształ jako składnik czynny |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9527836B2 (pl) |
| EP (1) | EP3041837B1 (pl) |
| JP (1) | JP5680161B1 (pl) |
| KR (1) | KR20160053915A (pl) |
| CN (1) | CN105518002A (pl) |
| PL (1) | PL3041837T3 (pl) |
| WO (1) | WO2015033612A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5951864B1 (ja) * | 2015-06-05 | 2016-07-13 | 株式会社ポーラファルマ | 抗ジアルジア剤 |
| JP2017101009A (ja) | 2015-12-04 | 2017-06-08 | 株式会社ポーラファルマ | 抗アカントアメーバ剤及びその製造法 |
| JP6085706B1 (ja) * | 2016-03-31 | 2017-02-22 | 株式会社ポーラファルマ | 抗トリトリコモナス剤 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60218387A (ja) | 1984-04-14 | 1985-11-01 | Nippon Nohyaku Co Ltd | ケテンｓ，ｓ−アセタ−ル類 |
| JP3081766B2 (ja) | 1994-05-06 | 2000-08-28 | 東興薬品工業株式会社 | 角質貯留型抗真菌外用組成物 |
| CN1091596C (zh) * | 1995-07-08 | 2002-10-02 | 日本农药株式会社 | 抗真菌剂及其化合物和它们的制备方法 |
| JP3278738B2 (ja) * | 1995-07-08 | 2002-04-30 | 日本農薬株式会社 | 抗真菌剤 |
| NZ519984A (en) | 2000-01-07 | 2004-03-26 | Transform Pharmaceuticals Inc | High-throughput formation, identification, and analysis of diverse solid-forms |
| JP2002114680A (ja) | 2000-07-31 | 2002-04-16 | Nippon Nohyaku Co Ltd | 抗真菌剤 |
| US20070082870A1 (en) * | 2005-10-11 | 2007-04-12 | Buchanan Charles M | Pharmaceutical formulations of cyclodextrins and antifungal azole compounds |
| JP5184342B2 (ja) | 2006-03-08 | 2013-04-17 | 日本農薬株式会社 | 外用の医薬組成物 |
| PL2005958T3 (pl) | 2006-03-08 | 2013-11-29 | Nihon Nohyaku Co Ltd | Kompozycja farmaceutyczna do stosowania zewnętrznego |
| JP5184341B2 (ja) | 2006-03-08 | 2013-04-17 | 日本農薬株式会社 | 外用の医薬組成物 |
| US8492421B2 (en) | 2007-08-27 | 2013-07-23 | Nihon Nohyaku Co., Ltd. | Agent for fungal dermatitis |
| HUE030028T2 (en) | 2007-09-05 | 2017-04-28 | Pola Pharma Inc | Antifungal drug |
| US20100204293A1 (en) | 2007-09-05 | 2010-08-12 | Pola Pharma Inc. | Pharmaceutical composition |
| WO2009031643A1 (ja) | 2007-09-05 | 2009-03-12 | Pola Pharma Inc. | 抗真菌組成物 |
| EP2395839B1 (en) | 2009-02-13 | 2014-05-07 | Topica Pharmaceuticals, Inc | Anti-fungal formulation |
| EP2416757A2 (en) | 2009-04-09 | 2012-02-15 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| JP5688406B2 (ja) | 2009-04-09 | 2015-03-25 | 株式会社ポーラファルマ | 抗真菌医薬組成物 |
| EP2470178B1 (en) | 2009-08-25 | 2018-10-17 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| US8962669B2 (en) | 2010-06-11 | 2015-02-24 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| CN103012385B (zh) * | 2012-02-17 | 2015-07-08 | 山东威智医药工业有限公司 | 卢立康唑的晶型及其制备方法 |
| RU2621615C2 (ru) | 2012-09-14 | 2017-06-06 | Пола Фарма Инк. | Фармацевтическая композиция, содержащая луликоназол |
| JP5460797B1 (ja) | 2012-09-14 | 2014-04-02 | 株式会社ポーラファルマ | アミド誘導体及び安定性指標としてのその使用 |
| CN104619704B (zh) * | 2012-09-14 | 2017-12-05 | 宝丽制药股份有限公司 | 表面自由能用于分化评价晶体的用途，基于表面自由能作为指标评价的晶体，以及通过包含所述晶体制备的药物组合物 |
| JP5589130B1 (ja) * | 2012-09-14 | 2014-09-10 | 株式会社ポーラファルマ | 結晶及び該結晶を含有してなる医薬製剤 |
| IN2015DN02376A (pl) * | 2012-09-14 | 2015-09-04 | Pola Pharma Inc | |
| US20150366845A1 (en) | 2013-01-28 | 2015-12-24 | Pola Pharma Inc., | Pharmaceutical composition for diseases caused by pathogenic microorganisms such as aspergillus |
| JP6254597B2 (ja) | 2013-01-28 | 2017-12-27 | 株式会社ポーラファルマ | カンジダ等の病原微生物による疾患用の医薬組成物 |
| JP5589110B1 (ja) | 2013-03-08 | 2014-09-10 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
| JP2016518306A (ja) | 2013-05-17 | 2016-06-23 | 株式会社ポーラファルマ | アスペルギルス、カンジダ等を病原体とする疾患用の医薬組成物 |
-
2013
- 2013-09-06 JP JP2013185313A patent/JP5680161B1/ja active Active
-
2014
- 2014-04-11 US US14/419,864 patent/US9527836B2/en active Active
- 2014-04-11 EP EP14722366.3A patent/EP3041837B1/en active Active
- 2014-04-11 WO PCT/JP2014/060993 patent/WO2015033612A1/en not_active Ceased
- 2014-04-11 PL PL14722366T patent/PL3041837T3/pl unknown
- 2014-04-11 KR KR1020167005103A patent/KR20160053915A/ko not_active Ceased
- 2014-04-11 CN CN201480048566.XA patent/CN105518002A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3041837A1 (en) | 2016-07-13 |
| KR20160053915A (ko) | 2016-05-13 |
| CN105518002A (zh) | 2016-04-20 |
| US9527836B2 (en) | 2016-12-27 |
| JP2015051945A (ja) | 2015-03-19 |
| EP3041837B1 (en) | 2021-10-13 |
| WO2015033612A1 (en) | 2015-03-12 |
| JP5680161B1 (ja) | 2015-03-04 |
| US20160168136A1 (en) | 2016-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285390A (en) | Arylquinazolines, their preparation and pharmaceutical preparations containing them | |
| IL263978B (en) | Amorphous latrovir and solid pharmaceutical preparations containing it and its uses | |
| RU2016118771A3 (en) | Co-crystals and pharmaceutical compositions comprising the same | |
| IL244206A0 (en) | A pharmaceutical preparation containing a pyrimidine compound as an active ingredient | |
| IL240290B (en) | History of pyridazinone-amide and pharmaceutical preparations containing them | |
| EP3043824A4 (en) | Modified therapeutic agents and compositions thereof | |
| PT3043773T (pt) | Composição farmacêutica de dose fixa estável composta por mometasona e olopatadina para administração nasal | |
| ZA201509307B (en) | Pharmaceutical composition, preparation and uses thereof | |
| ZA201505318B (en) | 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions | |
| EP2976091C0 (de) | Antioxidativ wirksame zusammensetzung und deren verwendung | |
| GB2519982B (en) | Fungicidal composition and the use thereof | |
| EP3087987A4 (en) | Pharmaceutical composition containing palonosetron | |
| PT2988733T (pt) | Composição farmacêutica contendo macitentano cristalino | |
| EP2989093A4 (en) | NOVEL DERIVATIVES OF TRIAZOLONE OR THEIR SALTS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | |
| IL244693A0 (en) | History of piperazine and their use as drugs | |
| IL240875A0 (en) | Heterocyclic compounds and pharmaceutical preparations containing them | |
| IL240292B (en) | History of quinazoline and pharmaceutical preparations containing them | |
| TWI562776B (en) | Pharmaceutical composition and uses thereof | |
| EP3078671A4 (en) | Gemcitabine derivative, composition containing the derivative and pharmaceutical use of the derivative | |
| PL3041837T3 (pl) | Kryształ o specyficznym pokroju kryształu i kompozycja farmaceutyczna zawierająca ten kryształ jako składnik czynny | |
| GB201307082D0 (en) | Pharmaceutical composition comprising 15-HETrE and methods of using the same | |
| EP3087979A4 (en) | Sustained-release pharmaceutical composition containing acebrophylline and hydrophobic sustained-release agent | |
| HRP20171815T1 (hr) | Stabilni farmaceutski pripravak koji sadrži amorfni rosuvastatin-kalcij | |
| EP3195864A4 (en) | Pharmaceutical composition containing an analgesic agent and an antispasmosdic agent | |
| EP3048886A4 (en) | 3, 4-bis-benzylsulfonylbutanenitrile and its pharmaceutical use |